Physician profile
Michelle E Day
NPI 1235180092
$10,383.96
in general payments reported to CMS, 2019-2025
11 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,233 · 2022: $810 · 2023: $1,542 · 2024: $5,211 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,325 · Food and Beverage: $2,246 · Consulting Fee: $600 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,325.00 |
| Food and Beverage | $2,245.64 |
| Consulting Fee | $600.00 |
| Education | $169.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $5,684.74 | 2021-2024 | Xarelto, Spotlight |
| E.R. Squibb & Sons, L.L.C. | $3,526.93 | 2021-2025 | Eliquis, Camzyos |
| Alexion Pharmaceuticals, INC. | $571.34 | 2024-2025 | Ultomiris, Soliris |
| Daiichi Sankyo INC. | $199.73 | 2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $124.65 | 2023 | Calquence |
| Beigene USA, INC. | $88.85 | 2025 | Brukinsa |
| Pfizer INC. | $59.53 | 2021-2024 | |
| Novocure INC. | $59.35 | 2025 | Optune Lua (Novottf-200t) |
| Emd Serono, INC. | $24.51 | 2025 | |
| Servier Pharmaceuticals LLC | $23.63 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.